                         SEQUENCE LISTING

<110>  The University of Queensland
 
<120>  Neurotropin-Tyrosine kinase receptor Signaling

<130>  P91365.PCT

<140>  AU 2012904244
<141>  2013-09-27

<150>  2012904244
<151>  2012-09-28

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  155
<212>  PRT
<213>  Human

<400>  1

Lys Arg Trp Asn Ser Cys Lys Gln Asn Lys Gln Gly Ala Asn Ser Arg 
1               5                   10                  15      


Pro Val Asn Gln Thr Pro Pro Pro Glu Gly Glu Lys Leu His Ser Asp 
            20                  25                  30          


Ser Gly Ile Ser Val Asp Ser Gln Ser Leu His Asp Gln Gln Pro His 
        35                  40                  45              


Thr Gln Thr Ala Ser Gly Gln Ala Leu Lys Gly Asp Gly Gly Leu Tyr 
    50                  55                  60                  


Ser Ser Leu Pro Pro Ala Lys Arg Glu Glu Val Glu Lys Leu Leu Asn 
65                  70                  75                  80  


Gly Ser Ala Gly Asp Thr Trp Arg His Leu Ala Gly Glu Leu Gly Tyr 
                85                  90                  95      


Gln Pro Glu His Ile Asp Ser Phe Thr His Glu Ala Cys Pro Val Arg 
            100                 105                 110         


Ala Leu Leu Ala Ser Trp Ala Thr Gln Asp Ser Ala Thr Leu Asp Ala 
        115                 120                 125             


Leu Leu Ala Ala Leu Arg Arg Ile Gln Arg Ala Asp Leu Val Glu Ser 
    130                 135                 140                 


Leu Cys Ser Glu Ser Thr Ala Thr Ser Pro Val 
145                 150                 155 


<210>  2
<211>  29
<212>  PRT
<213>  Artificial

<220>
<223>  c29- Fragment of p75ICD

<400>  2

Lys Arg Trp Asn Ser Cys Lys Gln Asn Lys Gln Gly Ala Asn Ser Arg 
1               5                   10                  15      


Pro Val Asn Gln Thr Pro Pro Pro Glu Gly Glu Lys Leu 
            20                  25                  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  c1-14 - Fragment of p75ICD

<400>  3

Lys Arg Trp Asn Ser Cys Lys Gln Asn Lys Gln Gly Ala Asn 
1               5                   10                  


<210>  4
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  c1-6 - Fragment of p75ICD

<400>  4

Lys Arg Trp Asn Ser Cys 
1               5       


<210>  5
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  c15-29 - Fragment of p75ICD

<400>  5

Ser Arg Pro Val Asn Gln Thr Pro Pro Pro Glu Gly Glu Lys Leu 
1               5                   10                  15  


<210>  6
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  c15-21 - Fragment of p75ICD

<400>  6

Ser Arg Pro Val Asn Gln Thr 
1               5           


<210>  7
<211>  40
<212>  PRT
<213>  Artificial

<220>
<223>  TAT-c29 - Fusion of TAT with c29

<400>  7

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala Lys Arg Trp Asn Ser 
1               5                   10                  15      


Cys Lys Gln Asn Lys Gln Gly Ala Asn Ser Arg Pro Val Asn Gln Thr 
            20                  25                  30          


Pro Pro Pro Glu Gly Glu Lys Leu 
        35                  40  


<210>  8
<211>  25
<212>  PRT
<213>  Artificial

<220>
<223>  TAT-c1-14 - Fusion of TAT and c1-4

<400>  8

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala Lys Arg Trp Asn Ser 
1               5                   10                  15      


Cys Lys Gln Asn Lys Gln Gly Ala Asn 
            20                  25  


<210>  9
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  TAT-c1-6 - Fusion of TAT and c1-6

<400>  9

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala Lys Arg Trp Asn Ser 
1               5                   10                  15      


Cys 
    


<210>  10
<211>  26
<212>  PRT
<213>  Artificial

<220>
<223>  TAT-c15-21 - Fusion of TAT and c15-29

<400>  10

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala Ser Arg Pro Val Asn 
1               5                   10                  15      


Gln Thr Pro Pro Pro Glu Gly Glu Lys Leu 
            20                  25      


<210>  11
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  TAT-c 15-21 - Fusion of TAT and c15-21

<400>  11

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala Ser Arg Pro Val Asn 
1               5                   10                  15      


Gln Thr 
        


<210>  12
<211>  166
<212>  PRT
<213>  Artificial

<220>
<223>  TAT-p75ICD - Fusion of TAT and p75ICD

<400>  12

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala Lys Arg Trp Asn Ser 
1               5                   10                  15      


Cys Lys Gln Asn Lys Gln Gly Ala Asn Ser Arg Pro Val Asn Gln Thr 
            20                  25                  30          


Pro Pro Pro Glu Gly Glu Lys Leu His Ser Asp Ser Gly Ile Ser Val 
        35                  40                  45              


Asp Ser Gln Ser Leu His Asp Gln Gln Pro His Thr Gln Thr Ala Ser 
    50                  55                  60                  


Gly Gln Ala Leu Lys Gly Asp Gly Gly Leu Tyr Ser Ser Leu Pro Pro 
65                  70                  75                  80  


Ala Lys Arg Glu Glu Val Glu Lys Leu Leu Asn Gly Ser Ala Gly Asp 
                85                  90                  95      


Thr Trp Arg His Leu Ala Gly Glu Leu Gly Tyr Gln Pro Glu His Ile 
            100                 105                 110         


Asp Ser Phe Thr His Glu Ala Cys Pro Val Arg Ala Leu Leu Ala Ser 
        115                 120                 125             


Trp Ala Thr Gln Asp Ser Ala Thr Leu Asp Ala Leu Leu Ala Ala Leu 
    130                 135                 140                 


Arg Arg Ile Gln Arg Ala Asp Leu Val Glu Ser Leu Cys Ser Glu Ser 
145                 150                 155                 160 


Thr Ala Thr Ser Pro Val 
                165     


<210>  13
<211>  11
<212>  PRT
<213>  Human immunodeficiency virus

<400>  13

Tyr Ala Arg Ala Ala Ala Arg Asn Ala Arg Ala 
1               5                   10      


